3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
68
Leukemia
56
Myelodysplastic Syndromes
53
Lymphoma
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Lymphoma, Non-Hodgkin
43
Multiple Myeloma
40
Hodgkin Disease
39
Leukemia, Lymphocytic, Chronic, B-Cell
35
Congenital Abnormalities
30
Lymphoma, Follicular
28
Lymphoma, Large B-Cell, Diffuse
27
Lymphoma, Mantle-Cell
26
Neoplasms, Plasma Cell
25
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
23
Burkitt Lymphoma
23
Myeloproliferative Disorders
22
Lymphoma, Large-Cell, Immunoblastic
22
Leukemia, Myelomonocytic, Chronic
22
Blast Crisis
22
Leukemia, Myeloid, Chronic-Phase
21
Leukemia, Myeloid, Accelerated Phase
21
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
15
Hematologic Neoplasms
15
Graft vs Host Disease
15
Dendritic Cell Sarcoma, Interdigitating
14
Anemia, Refractory, with Excess of Blasts
14
Waldenstrom Macroglobulinemia
13
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Busulfan
×
Clear all
No trials found.